Unknown

Dataset Information

Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up.


ABSTRACT:

Background

Continuous intraperitoneal insulin infusion (CIPII) with an implantable pump is a treatment option for patients with type 1 diabetes mellitus (T1DM). Aim of the present study was to describe the long-term course of glycaemic control, complications, health related quality of life (HRQOL) and treatment satisfaction among T1DM patients treated with CIPII.

Methods

Nineteen patients that participated in a randomized cross-over trial comparing CIPII and subcutaneous (SC) therapy in 2006 were followed until 2012. Laboratory, continuous glucose monitoring, HRQOL and treatment satisfaction measurements were performed at the start of the study, the end of the SC-, the end of the CIPII treatment phase in 2006 and during CIPII therapy in 2012. Linear mixed models were used to

SUBMITTER: van Dijk PR 

PROVIDER: S-EPMC4029992 | biostudies-literature | 2014 Apr

REPOSITORIES: biostudies-literature